Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
Xing-Hao Zhou, Jingru Li, Tang‐Hui Zheng, et al.
Clinical & Experimental Metastasis (2022) Vol. 40, Iss. 1, pp. 5-32
Closed Access | Times Cited: 15

Showing 15 citing articles:

Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score
Jiawei Lin, Jie Li, Yifan Kong, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma
Zhenli Li, Mingda Zhao, Xingshun Qi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 15, pp. 2103-2111
Open Access | Times Cited: 12
Ascitic microbiota alteration is associated with portal vein tumor thrombosis occurrence and prognosis in hepatocellular carcinoma
Y. Guo, Shan Tian, Na Zhan, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 2
Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice
Ling Chen, Susu Liu, Yuya Wang, et al.
动物学研究 (2024) Vol. 45, Iss. 3, pp. 551-566
Open Access | Times Cited: 2
The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma
Linda Galasso, Lucia Cerrito, Fabrizio Termite, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3247-3247
Open Access | Times Cited: 2
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients
Andrea Dalbeni, Filippo Cattazzo, Leonardo De Marco, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 3, pp. 477-483
Open Access | Times Cited: 6
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study
Haohao Lu, Chuansheng Zheng, Bin Liang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Identification of key molecules in the formation of portal vein tumor thrombus in hepatocellular carcinoma based on single cell transcriptomics and in vitro experiments
Man Zhang, Chenglei Su, Xiaoyu Liu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1737-1761
Open Access | Times Cited: 1
Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis
Raluca Mititelu, Alexandru Mitoi, Cătălin Mazilu, et al.
Nuclear Medicine Communications (2024) Vol. 45, Iss. 8, pp. 651-657
Closed Access | Times Cited: 1
Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Wanxin Shi, Huiwen Yan, Xiaoli Liu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1049-1063
Open Access | Times Cited: 1
Nir-triggered arsenic-loaded layered double hydroxide-based films for localized thermal synergistic chemotherapy
Shun Xing, Haifeng Zhang, Zhenhao Hou, et al.
Journal of Colloid and Interface Science (2024) Vol. 675, pp. 857-869
Closed Access | Times Cited: 1
Calpain 2 promotes Lenvatinib resistance and cancer stem cell traits via both proteolysis-dependent and independent approach in hepatocellular carcinoma
Xiaolu Ma, Kaixia Zhou, Tianqing Yan, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
c‐Met inhibitor upregulates E‐cadherin, which is lost in portal vein tumor thrombus of hepatocellular carcinoma
Satoru Abe, Yoshinori Inagaki, Takashi Kokudo, et al.
Hepatology Research (2024) Vol. 55, Iss. 2, pp. 240-249
Open Access
Development and verification of a nomogram for predicting portal vein tumor thrombosis in hepatocellular carcinoma
Guanghua Liu, Jiangwen Long, Chaoshui Liu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 12, pp. 7511-7520
Closed Access
THE SURGEON'S PERSPECTIVE ON PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS
S. M. Vasyliuk, V. I. Hudyvok, I. R. Labiak, et al.
Art of Medicine (2023), pp. 152-157
Open Access
Page 1

Scroll to top